Tag: SGLT2 inhibitors kidney safety

Chronic Kidney Disease and Metformin or SGLT2 Inhibitors: Dosing and Safety Guidelines 2025

Posted by: Alan Burity Vitulo in: Health and Medicine

12 Dec | 13:41 PM | 0

Updated 2025 guidelines on using metformin and SGLT2 inhibitors safely in chronic kidney disease. Learn correct eGFR dosing thresholds, safety risks, combination therapy benefits, and what to do if your kidney function declines.

Adolescents and Psychiatric Medications: How to Monitor for Suicidal Ideation

Adolescents on psychiatric medications need close monitoring for suicidal ideation, especially in the first weeks of treatment. Learn the warning signs, best practices, and how families and providers can work together to keep teens safe.

Alcohol and Sleep Medications: The Hidden Danger of Combined Sedation

Mixing alcohol with sleep medications like Ambien or Lunesta can cause deadly sedation, slowed breathing, memory loss, and sleep-driving. No amount is safe. Learn the risks, the science, and what to do instead.

Levothyroxine Generics: When to Monitor TSH After Switching Products

Switching between generic levothyroxine brands is safe for most people, but some patients need TSH monitoring after a switch. Learn who should get tested and why.

How the FDA Monitors Generic Drug Safety After Approval

The FDA monitors generic drug safety after approval using real-world data, adverse event reports, and market analysis to catch manufacturing defects and therapeutic issues. Learn how the system works - and where it still has gaps.

Tag: SGLT2 inhibitors kidney safety

Chronic Kidney Disease and Metformin or SGLT2 Inhibitors: Dosing and Safety Guidelines 2025

recent posts

categories

archives

tags